Abstract

It is estimated that the global market size of ‘Digital Health' will increase drastically to more than $200B, and the market attracts a lot of companies all over the world. In such a setting, “How can Japan win the game by using our advantages?”

In most false cases of medical device development in Japan, it was found that the companies could not identify the appropriate needs while they had sets of very good high-techs. Namely, finding good needs is the critical factor for success in the development of medical device business, especially in Japan.

The Stanford Biodesign process, that is the need-pull process for medical device development, can be one of the best solutions to overcome this situation.

Therefore, we launched Japan Biodesign last year in collaboration with Stanford Biodesign in order to develop the global leaders that can perform the need-pull development process for medtech/healthcare innovation.